259 related articles for article (PubMed ID: 26997507)
1. The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant.
Moskal JR; Burgdorf JS; Stanton PK; Kroes RA; Disterhoft JF; Burch RM; Khan MA
Curr Neuropharmacol; 2017; 15(1):47-56. PubMed ID: 26997507
[TBL] [Abstract][Full Text] [Related]
2. The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus.
Burgdorf J; Zhang XL; Weiss C; Gross A; Boikess SR; Kroes RA; Khan MA; Burch RM; Rex CS; Disterhoft JF; Stanton PK; Moskal JR
Neuroscience; 2015 Nov; 308():202-11. PubMed ID: 26343295
[TBL] [Abstract][Full Text] [Related]
3. Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats.
Burgdorf J; Kroes RA; Zhang XL; Gross AL; Schmidt M; Weiss C; Disterhoft JF; Burch RM; Stanton PK; Moskal JR
Behav Brain Res; 2015 Nov; 294():177-85. PubMed ID: 26210936
[TBL] [Abstract][Full Text] [Related]
4. Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-Like Effects.
Donello JE; Banerjee P; Li YX; Guo YX; Yoshitake T; Zhang XL; Miry O; Kehr J; Stanton PK; Gross AL; Burgdorf JS; Kroes RA; Moskal JR
Int J Neuropsychopharmacol; 2019 Mar; 22(3):247-259. PubMed ID: 30544218
[TBL] [Abstract][Full Text] [Related]
5. GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.
Burgdorf J; Zhang XL; Nicholson KL; Balster RL; Leander JD; Stanton PK; Gross AL; Kroes RA; Moskal JR
Neuropsychopharmacology; 2013 Apr; 38(5):729-42. PubMed ID: 23303054
[TBL] [Abstract][Full Text] [Related]
6. NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and Memory.
Khan MA; Houck DR; Gross AL; Zhang XL; Cearley C; Madsen TM; Kroes RA; Stanton PK; Burgdorf J; Moskal JR
Int J Neuropsychopharmacol; 2018 Mar; 21(3):242-254. PubMed ID: 29099938
[TBL] [Abstract][Full Text] [Related]
7. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
[TBL] [Abstract][Full Text] [Related]
8. NMDA receptor partial agonist GLYX-13 alleviates chronic stress-induced depression-like behavior through enhancement of AMPA receptor function in the periaqueductal gray.
Yang PS; Peng HY; Lin TB; Hsieh MC; Lai CY; Lee AS; Wang HH; Ho YC
Neuropharmacology; 2020 Nov; 178():108269. PubMed ID: 32791085
[TBL] [Abstract][Full Text] [Related]
9. Insulin-Like Growth Factor I Produces an Antidepressant-Like Effect and Elicits N-Methyl-D-Aspartate Receptor Independent Long-Term Potentiation of Synaptic Transmission in Medial Prefrontal Cortex and Hippocampus.
Burgdorf J; Zhang XL; Colechio EM; Ghoreishi-Haack N; Gross A; Kroes RA; Stanton PK; Moskal JR
Int J Neuropsychopharmacol; 2015 Sep; 19(2):. PubMed ID: 26374350
[TBL] [Abstract][Full Text] [Related]
10. Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants.
Wang YT; Zhang NN; Liu LJ; Jiang H; Hu D; Wang ZZ; Chen NH; Zhang Y
Biochem Biophys Res Commun; 2022 Feb; 594():46-56. PubMed ID: 35074585
[TBL] [Abstract][Full Text] [Related]
11. The N-methyl-D-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats.
Burgdorf J; Zhang XL; Weiss C; Matthews E; Disterhoft JF; Stanton PK; Moskal JR
Neurobiol Aging; 2011 Apr; 32(4):698-706. PubMed ID: 19446371
[TBL] [Abstract][Full Text] [Related]
12. Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms.
Kato T; Duman RS
Pharmacol Biochem Behav; 2020 Jan; 188():172827. PubMed ID: 31733218
[TBL] [Abstract][Full Text] [Related]
13. GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists.
Moskal JR; Burch R; Burgdorf JS; Kroes RA; Stanton PK; Disterhoft JF; Leander JD
Expert Opin Investig Drugs; 2014 Feb; 23(2):243-54. PubMed ID: 24251380
[TBL] [Abstract][Full Text] [Related]
14. GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice.
Rajagopal L; Burgdorf JS; Moskal JR; Meltzer HY
Behav Brain Res; 2016 Feb; 299():105-10. PubMed ID: 26632337
[TBL] [Abstract][Full Text] [Related]
15. Rapastinel, an NMDAR positive modulator, produces distinct behavioral, sleep, and EEG profiles compared with ketamine.
Banerjee P; Donello JE; Hare B; Duman RS
Behav Brain Res; 2020 Aug; 391():112706. PubMed ID: 32461133
[TBL] [Abstract][Full Text] [Related]
16. GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator.
Moskal JR; Kuo AG; Weiss C; Wood PL; O'Connor Hanson A; Kelso S; Harris RB; Disterhoft JF
Neuropharmacology; 2005 Dec; 49(7):1077-87. PubMed ID: 16051282
[TBL] [Abstract][Full Text] [Related]
17. GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine.
Liu RJ; Duman C; Kato T; Hare B; Lopresto D; Bang E; Burgdorf J; Moskal J; Taylor J; Aghajanian G; Duman RS
Neuropsychopharmacology; 2017 May; 42(6):1231-1242. PubMed ID: 27634355
[TBL] [Abstract][Full Text] [Related]
18. Rapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date.
Ragguett RM; Rong C; Kratiuk K; McIntyre RS
Expert Opin Investig Drugs; 2019 Feb; 28(2):113-119. PubMed ID: 30585524
[TBL] [Abstract][Full Text] [Related]
19. Esketamine and rapastinel, but not imipramine, have antidepressant-like effect in a treatment-resistant animal model of depression.
Pereira VS; Joca SRL; Harvey BH; Elfving B; Wegener G
Acta Neuropsychiatr; 2019 Oct; 31(5):258-265. PubMed ID: 31230597
[TBL] [Abstract][Full Text] [Related]
20. PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13.
Lu Y; Wang C; Xue Z; Li C; Zhang J; Zhao X; Liu A; Wang Q; Zhou W
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25542689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
